Table 1 Evaluation of drug contents of vorinostat-NPs
From: Antitumor activity of vorinostat-incorporated nanoparticles against human cholangiocarcinoma cells
| Â | Polymer/vorinostat weight ratio (mg/mg) | Drug contents (%, w/w) | |
|---|---|---|---|
Theoretical | Experimental | ||
Empty | 100/0 | – | – |
Vorinostat-NP10 | 100/10 | 9.1 | 8.3 |
Vorinostat-NP20 | 100/20 | 16.7 | 15.1 |